Abstract
Acute disseminated encephalomyelitis (ADEM) is a demyelinating syndrome of the central nervous system. It is considered to be an autoimmune response to an antecedent antigenic stimulus, most frequently a prior infectious illness (postinfectious encephalitis) or immunization (postvaccination encephalitis) occurring in the days or weeks before neurologic illness. Clinically, ADEM is characterized by encephalopathy, or focal/multifocal neurologic signs; brain MRI is characterized by diffuse multifocal or patchy areas of demyelination. The differentiation between ADEM and a first episode of multiple sclerosis, a chronic central nervous system demyelinating disease, may be difficult but has important prognostic and treatment implications. Although no clinical trials have assessed the efficacy of treatment modalities in patients with ADEM, immunomodulators, including corticosteroids and intravenous immunoglobulin, are frequently used empirically. ADEM outcome is generally favorable, with resolution over weeks to months.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References and Recommended Reading
Tenembaum S, Chitnis T, Ness J, Hahn JS: Acute disseminated encephalomyelitis. Neurology 2007, 68(16 Suppl 2):S23–S36.
Menge T, Hemmer B, Nessler S, et al.: Acute disseminated encephalomyelitis: an update. Arch Neurol 2005, 62:1673–1680.
Wingerchuk DM: Acute disseminated encephalomyelitis: distinction from multiple sclerosis and treatment issues. Adv Neurol 2006, 98:303–318.
Storch-Hagenlocher B, Griffin D: Acute disseminated encephalomyelitis (parainfectious and postvaccinial encephalitis). In Neuro Critical Care. Edited by Hacke W, Hanley D, Bleck T, Diringer M. Berlin: Springer-Verlag; 1994:493–499.
Postinfectious demyelinating disease. In Viral Infections of the Nervous System, 2nd edn. Edited by Johnson R. Philadelphia, New York: Lippincott-Raven Press; 1998:181–210.
Chardos JF, Smith D, Letendre S: Demyelinating encephalitis. Clin Infect Dis 2003, 36:1266–1267, 332–334.
Stone MJ, Hawkins CP: A medical overview of encephalitis. Neuropsychol Rehabil 2007, 17:429–449.
Geerts Y, Dehaene I, Lammens M: Acute hemorrhagic leukoencephalitis. Acta Neurol Belg 1991, 91:201–211.
Mizuguchi M: Acute necrotizing encephalopathy of childhood: a novel form of acute encephalopathy prevalent in Japan and Taiwan. Brain Dev 1997, 19:81–92.
Kirton A, Busche K, Ross C, Wirrell E: Acute necrotizing encephalopathy in Caucasian children: two cases and review of the literature. J Child Neurol 2005, 20:527–532.
Leake JA, Billman GF, Nespeca MP, et al.: Pediatric acute hemorrhagic leukencephalitis: report of a surviving patient and review. Clin Infect Dis 2002, 34:699–703.
Tenembaum S, Chamoles N, Fejerman N: Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients. Neurology 2002, 59:1224–1231.
Tenembaum SN: Disseminated encephalomyelitis in children. Clin Neurol Neurosurg 2008 (Epub ahead of print).
Young NP, Weinshenker BG, Lucchinetti CF: Acute disseminated encephalomyelitis: current understanding and controversies. Semin Neurol 2008, 28:84–94.
Murthy SN, Faden HS, Cohen ME, Bakshi R: Acute disseminated encephalomyelitis in children. Pediatrics 2002, 110(2 Pt 1):e21.
Fadil H, Kelley RE, Gonzalez-Toledo E: Differential diagnosis of multiple sclerosis. Int Rev Neurobiol 2007, 79:393–422.
Leake JA, Albani S, Kao AS, et al.: Acute disseminated encephalomyelitis in childhood: epidemiologic, clinical and laboratory features. Pediatr Infect Dis J 2004, 23:756–764.
Rivers TM, Schwentker FF. Encephalomyelitis accompanied by myelin destruction experimentally produced in monkeys. J Exp Med 1935, 61:689–702.
Kalume F, Lee SM, Morcos Y, et al.: Molecular mimicry: cross-reactive antibodies from patients with immune-mediated neurologic disease inhibit neuronal firing. J Neurosci Res 2004, 77:82–89.
Levin MC, Krichavsky M, Berk J, et al.: Neuronal molecular mimicry in immune-mediated neurologic disease. Ann Neurol 1998, 44:87–98.
Miller SD, Olson JK, Croxford JL: Multiple pathways to induction of virus-induced autoimmune demyelination: lessons from Theiler’s virus infection. J Autoimmun 2001, 16:219–227.
Olson JK, Eagar TN, Miller SD: Functional activation of myelin-specific T cells by virus-induced molecular mimicry. J Immunol 2002, 169:2719–2726.
Idrissova ZhR, Boldyreva MN, Dekonenko EP, et al.: Acute disseminated encephalomyelitis in children: clinical features and HLA-DR linkage. Eur J Neurol 2003, 10:537–546.
Oh HH, Kwon SH, Kim CW, et al.: Molecular analysis of HLA class II-associated susceptibility to neuroinflammatory diseases in Korean children. J Korean Med Sci 2004, 19:426–430.
Pittock SJ, McClelland RL, Achenbach SJ, et al.: Clinical course, pathological correlations, and outcome of biopsy proved inflammatory demyelinating disease. J Neurol Neurosurg Psychiatry 2005, 76:1693–1697.
Wegner C: Pathological differences in acute inflammatory demyelinating diseases of the central nervous system. Int MS J 2005, 12:13–19, 12.
Sejvar JJ, Bode AV, Curiel M, Marfin AA: Post-infectious encephalomyelitis associated with St. Louis encephalitis virus infection. Neurology 2004, 63:1719–1721.
Gibbs WN, Kreidie MA, Kim RC, Hasso AN: Acute hemorrhagic leukoencephalitis: neuroimaging features and neuropathologic diagnosis. J Comput Assist Tomogr 2005, 29:689–693.
Love S: Demyelinating diseases. J Clin Pathol 2006, 59:1151–1159.
Andreula C: Cranial viral infections in the adult. Eur Radiol 2004, 14(Suppl 3):E132–E144.
Hynson JL, Kornberg AJ, Coleman LT, et al.: Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children. Neurology 2001, 56:1308–1312.
de Seze J, Debouverie M, Zephir H, et al.: Acute fulminant demyelinating disease: a descriptive study of 60 patients. Arch Neurol 2007, 64:1426–1432.
Gabis LV, Panasci DJ, Andriola MR, Huang W: Acute disseminated encephalomyelitis: an MRI/MRS longitudinal study. Pediatr Neurol 2004, 30:324–329.
Schwarz S, Mohr A, Knauth M, et al.: Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients. Neurology 2001, 56:1313–1318.
Mikaeloff Y, Suissa S, Vallee L, et al.: First episode of acute CNS inflammatory demyelination in childhood: prognostic factors for multiple sclerosis and disability. J Pediatr 2004, 144:246–252.
Sejvar JJ, Kohl KS, Bilynsky R, et al.: Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 2007, 25:5771–5792.
Krupp LB, Banwell B, Tenembaum S: Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology 2007, 68(16 Suppl 2):S7–S12.
Singh S, Prabhakar S, Korah IP, et al.: Acute disseminated encephalomyelitis and multiple sclerosis: magnetic resonance imaging differentiation. Australas Radiol 2000, 44:404–411.
Mihai C, Jubelt B: Post-infectious encephalomyelitis. Curr Neurol Neurosci Rep 2005, 5:440–445.
Lin CH, Huang YC, Chiu CH, et al.: Neurologic manifestations in children with influenza B virus infection. Pediatr Infect Dis J 2006, 25:1081–1083.
Surtees R, DeSousa C: Influenza virus associated encephalopathy. Arch Dis Child 2006, 91:455–456.
Murphy J, Austin J: Spontaneous infection or vaccination as cause of acute disseminated encephalomyelitis. Neuroepidemiology 1985, 4:138–145.
Fenichel GM: Neurological complications of immunization. Ann Neurol 1982, 12:119–128.
Hemachudha T, Griffin DE, Giffels JJ, et al.: Myelin basic protein as an encephalitogen in encephalomyelitis and polyneuritis following rabies vaccination. N Engl J Med 1987, 316:369–374.
Takahashi H, Pool V, Tsai TF, Chen RT: Adverse events after Japanese encephalitis vaccination: review of post-marketing surveillance data from Japan and the United States. The VAERS Working Group. Vaccine 2000, 18:2963–2969.
Moore ZS, Seward JF, Lane JM: Smallpox. Lancet 2006, 367:425–435.
Lane JM, Ruben FL, Neff JM, Millar JD: Complications of smallpox vaccination, 1968. N Engl J Med 1969, 281:1201–1208.
Sejvar JJ, Labutta RJ, Chapman LE, et al.: Neurologic adverse events associated with smallpox vaccination in the United States, 2002–2004. JAMA 2005, 294:2744–2750.
Beleza P, Ribeiro M, Pereira J, et al.: Probable acute disseminated encephalomyelitis due to Haemophilus influenzae meningitis. Dev Med Child Neurol 2008, 50:388–391.
McMahon AW, Eidex RB, Marfin AA, et al.: Neurologic disease associated with 17D-204 yellow fever vacciantion: a report of 15 cases. Vaccine 2007, 25:1727–1734.
Henderson DA, Borio LL, Jane JM: Smallpox and vaccinia. In Vaccines, 4th edn. Edited by Plotkin SA, Orenstein WA. Philadelphia: Saunders; 2004:123–153.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sejvar, J.J. Acute disseminated encephalomyelitis. Curr Infect Dis Rep 10, 307–314 (2008). https://doi.org/10.1007/s11908-008-0050-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11908-008-0050-7